These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 23890057)

  • 1. A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of BALB/c and C57/BL6 mice in a model of limb ischemia.
    Cunha FF; Martins L; Martin PK; Stilhano RS; Han SW
    Stem Cell Res Ther; 2013 Jul; 4(4):86. PubMed ID: 23890057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
    Al-Rifai R; Nguyen P; Bouland N; Terryn C; Kanagaratnam L; Poitevin G; François C; Boisson-Vidal C; Sevestre MA; Tournois C
    J Transl Med; 2019 Aug; 17(1):261. PubMed ID: 31399109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
    Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
    Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow mesenchymal stem cell-derived endothelial cells increase capillary density and accelerate angiogenesis in mouse hindlimb ischemia model.
    Yao Z; Liu H; Yang M; Bai Y; Zhang B; Wang C; Yan Z; Niu G; Zou Y; Li Y
    Stem Cell Res Ther; 2020 Jun; 11(1):221. PubMed ID: 32513272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy.
    Nammian P; Asadi-Yousefabad SL; Daneshi S; Sheikhha MH; Tabei SMB; Razban V
    Stem Cell Res Ther; 2021 Jan; 12(1):58. PubMed ID: 33436054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients.
    Huang WH; Chen HL; Huang PH; Yew TL; Lin MW; Lin SJ; Hung SC
    Cardiovasc Res; 2014 Feb; 101(2):266-76. PubMed ID: 24220639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.
    Kwon YW; Heo SC; Jeong GO; Yoon JW; Mo WM; Lee MJ; Jang IH; Kwon SM; Lee JS; Kim JH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2136-44. PubMed ID: 23959047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of treatments of peripheral arterial disease with mesenchymal stromal cells and mesenchymal stromal cells modified with granulocyte and macrophage colony-stimulating factor.
    da Cunha FF; Martins L; Martin PK; Stilhano RS; Paredes Gamero EJ; Han SW
    Cytotherapy; 2013 Jul; 15(7):820-9. PubMed ID: 23660332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced angiogenesis by transplantation of mesenchymal stem cell sheet created by a novel magnetic tissue engineering method.
    Ishii M; Shibata R; Numaguchi Y; Kito T; Suzuki H; Shimizu K; Ito A; Honda H; Murohara T
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2210-5. PubMed ID: 21757660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases.
    Ledford KJ; Murphy N; Zeigler F; Bartel RL; Tubo R
    Stem Cell Res Ther; 2015 Mar; 6(1):25. PubMed ID: 25889271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenic properties of mesenchymal stem cells in a mouse model of limb ischemia.
    Martins L; Martin PK; Han SW
    Methods Mol Biol; 2014; 1213():147-69. PubMed ID: 25173381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of mouse adipose- and bone marrow mesenchymal stem cells in diabetic model with critical limb ischemia.
    Asadi-Yousefabad SL; Nammian P; Sheikhha MH; Tabei SMB; Daneshi S; Nikukar H; Lotfi M; Razban V
    Cell Tissue Bank; 2022 Dec; 23(4):923-936. PubMed ID: 35590084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel platelet lysate hydrogel for endothelial cell and mesenchymal stem cell-directed neovascularization.
    Robinson ST; Douglas AM; Chadid T; Kuo K; Rajabalan A; Li H; Copland IB; Barker TH; Galipeau J; Brewster LP
    Acta Biomater; 2016 May; 36():86-98. PubMed ID: 26961805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subacute limb ischemia induces skeletal muscle injury in genetically susceptible mice independent of vascular density.
    McClung JM; McCord TJ; Southerland K; Schmidt CA; Padgett ME; Ryan TE; Kontos CD
    J Vasc Surg; 2016 Oct; 64(4):1101-1111.e2. PubMed ID: 26254821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fucoidan protects mesenchymal stem cells against oxidative stress and enhances vascular regeneration in a murine hindlimb ischemia model.
    Han YS; Lee JH; Jung JS; Noh H; Baek MJ; Ryu JM; Yoon YM; Han HJ; Lee SH
    Int J Cardiol; 2015 Nov; 198():187-95. PubMed ID: 26163916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms.
    Kinnaird T; Stabile E; Burnett MS; Shou M; Lee CW; Barr S; Fuchs S; Epstein SE
    Circulation; 2004 Mar; 109(12):1543-9. PubMed ID: 15023891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia.
    Thej C; Balasubramanian S; Rengasamy M; Walvekar A; Swamynathan P; Raj SS; Shahani P; Siddikuzzaman ; Kolkundkar U; Seetharam RN; Gupta PK; Majumdar AS
    Stem Cell Res Ther; 2021 May; 12(1):279. PubMed ID: 33971964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fat extract promotes angiogenesis in a murine model of limb ischemia: a novel cell-free therapeutic strategy.
    Yu Z; Cai Y; Deng M; Li D; Wang X; Zheng H; Xu Y; Li W; Zhang W
    Stem Cell Res Ther; 2018 Nov; 9(1):294. PubMed ID: 30409190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the differential mechanisms of revascularization promoted by MSCs & ECFCs from adipose tissue or umbilical cord in a murine model of critical limb-threatening ischemia.
    Rojas-Torres M; Beltrán-Camacho L; Martínez-Val A; Sánchez-Gomar I; Eslava-Alcón S; Rosal-Vela A; Jiménez-Palomares M; Doiz-Artázcoz E; Martínez-Torija M; Moreno-Luna R; Olsen JV; Duran-Ruiz MC
    J Biomed Sci; 2024 Jul; 31(1):71. PubMed ID: 39004727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WKYMVm-induced activation of formyl peptide receptor 2 stimulates ischemic neovasculogenesis by promoting homing of endothelial colony-forming cells.
    Heo SC; Kwon YW; Jang IH; Jeong GO; Yoon JW; Kim CD; Kwon SM; Bae YS; Kim JH
    Stem Cells; 2014 Mar; 32(3):779-90. PubMed ID: 24155208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.